Aspirin Use and Risk of Fatal Cancer

Cancer Research

Volumn 53, Issue 6, 1993, Pages 1322-1327

  Flanders, W Dana ^b   Namboodiri, Mohan M ^a   Calle, Eugenia E ^a   Heath, Clark W ^a  

^a AMERICAN CANCER SOCIETY   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANACIN; PARACETAMOL;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RISK; COLON CANCER; DRUG USE; ESOPHAGUS CANCER; FEMALE; HUMAN; HUMAN TISSUE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; RECTUM CANCER; STOMACH CANCER;

ACETAMINOPHEN; ASPIRIN; COLONIC NEOPLASMS; DIGESTIVE SYSTEM NEOPLASMS; ESOPHAGEAL NEOPLASMS; FEMALE; HUMAN; MALE; MIDDLE AGE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; RISK; STOMACH NEOPLASMS;

EID: 0027512524     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (95)

1. Marne, L. J. Aspirin and the role of prostaglandins in cancer. Cancer Res. 52: 5575-5589, 1992.
2. Pollard, M. and Luckert, P. H. Indomethacin treatment of rats with dimethylhydra-zine-induced intestinal tumors. Cancer Treat. Rep. 64: 1323-1327, 1980.
3. Kudo, T. Narisawa, T. and Abo, S. Antitumor activity of indomethacin on methy-lazoxymethanol-induced large bowel tumors in rats. Gann, 71: 260-264, 1980.
4. Pollard, M. and Luckert, P. H. Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine. Science (Washington DC), 274:558-559, 1981.
5. Pollard M. and Luckert, P. H. Treatment of chemically-induced intestinal cancers with indomethacin. Proc. Soc. Exp. Biol. Med. 167: 161-164, 1981.
6. Narisawa, T. Sato, M’ Tani, M. Kudo, T. Takahashi, T. and Goto, A. Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment. Cancer Res. 41: 1954-1957, 1981.
7. Pollard, M. Luckert, P. H. and Schmidt, M. A. The suppressive effect of piroxicam on autochthonous intestinal tumors in the rat. Cancer Lett. 21: 57-61, 1983.
8. Pollard, M. and Luckert, P. H. Prolonged antitumor effect of indomethacin on autochthonous intestinal tumors in rats. J. Natl. Cancer Inst. 70: 1103-1105, 1983.
9. Narisawa, T. Satoh, M. Sano, M. and Takahashi, T. Inhibition of initiation and promotion by N-methylnitrosourea-induced colon carcinogenesis in rats by nonsteroid anti-inflammatory agent indomethacin. Carcinogenesis (Lond.), 4: 1225- 1227, 1983.
10. Pollard, M. and Luckert, P. H. Effect of piroxicam on primary intestinal tumors induced in rats by W-methylnitrosourea. Cancer Lett. 25: 117-121, 1984.
11. Narisawa, T. Hermanek, P. Habs, M. and Schmahl, D. Reduction of carcinogenicity of W-nitrosomethylurea by indomethacin and failure of resuming effect of prostaglandin E2 (PGE2) against indomethacin. J. Cancer Res. Clin. Oncol. 108: 239-242, 1984.
12. Metzger, U. Meier, J. Uhlschmid, G. and Weihe, H. Influence of various prostaglandin synthesis inhibitors on DMH-induced rat colon cancer. Dis. Colon Rectum, 27: 366-369, 1984.
13. Pollard, M. Antitumor effect of indomethacin in rats with autochthonous intestinal tumors. In: B. Levin and R. H. Riddell (eds.). Frontiers in Gastrointestinal Cancer, pp. 91-103. New York: Elsevier Publishing Co. 1984.
14. Nigra, D. N. Bull, A. W. and Boyd, M. E. Inhibition of intestinal carcinogenesis in rats: effect of difluoromethylomithine with piroxicam or fish oil. J. Natl. Cancer Inst. 77: 1309-1313, 1986.
15. Reddy, B. S. Maruyama, H. and Kelloff, G. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal anti-inflammatory drug, during different stages of rat colon tumor development. Cancer Res. 47: 5340-5346, 1987.
16. Moorghen, M. Ince, P. Finney, K. Sunter, J. P. Appleton, D. R. and Watson, A. J. A protective effect of sulindac against chemically-induced primary colonic tumors in mice. J. Pathol. 156: 341-347, 1988.
17. Pollard, M. and Luckert, P. H. Prevention and treatment of primary intestinal tumors in rats by piroxicam. Cancer Res. 49: 6471-6473, 1989.
18. Rubio, C. A. Wallin, B. Ware, J. Sveander, M. and Duvander, A. Effect of indomethacin in autotransplanted colonic tumors. Dis. Colon Rectum, 32: 488-491, 1989.
19. Reddy, B. S. Nayini, J. Tokumo, K. Rigotty, J. Zang, E. and Kelloff, G. Chemo-prevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal anti-inflammatory drug with D,L-a-difluoromethylomithine, an ornithine decarboxylase inhibitor, in diet. Cancer Res. 50: 2562-2568, 1990.
20. Rao, C. V. Tokumo, K. Rigotty, J. Zang, E. Kelloff, G. and Reddy, B. S. Chemo-prevention of colon carcinogenesis by dietary administration of piroxicam, ot-diflu-oromethylornithine, 16a-fluoro-5-androsten-17-one, and ellagic acid individually and in combination. Cancer Res. 51: 4528-4534, 1991.
21. Skinner, S. A. Penney, A. G. and O'Brian, P. E. Sulindac inhibits the rate of growth and appearance of colon tumors in the rat. Arch. Surg. 126: 1094-1096, 1991.
22. Craven, P. A. and Derubertis, F. R. Effects of aspirin on 1, -dimethylhydrazine-induced colonic carcinogenesis. Carcinogenesis (Lond.), 13: 541-546, 1992.
23. Tanaka, T. Nishikawa, A. Mori, Y. Morishita, M. and Mori, H. Inhibitory effects of non-steroidal anti-inflammatory drugs, piroxicam and indomethacin on 4-nitroquin-oline 1-oxide-induced tongue carcinogenesis in male ACI/N rats. Cancer Lett. 48: 177-182, 1989.
24. Rubio, C. A. Antitumoral activity of indomethacin on experimental esophageal tumors. J. Natl. Cancer Inst. 72: 705-707, 1984.
25. Rubio, C. A. Further studies on the therapeutic effect of indomethacin on esophageal tumors. Cancer (Phila.), 58: 1029-1031, 1986.
26. Takahashi, M. Furukawa, F. Toyoda, K. Sato, H. Hasegawa, R. Imaida, K. and Hayashi, Y. Effects of various prostaglandin synthesis inhibitors on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine. Carcinogenesis (Lond.), ll: 393-395, 1990.
27. Murasaki, G. Zenser, T. V. Davis, B. B. and Cohen, S. M. Inhibition by aspirin of JV-[4-(5 nitro-2-furyl)-2-thiazolyl]formamide-induced bladder carcinogenesis and enhancement of forestomach carcinogenesis. Carcinogenesis (Lond.), 5: 53-55, 1984.
28. Hasegawa, R. St. John, M. Murasaki, G. Fukushima, S. and Cohen, S. Effect of aspirin on yV-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced epithelial proliferation in the urinary bladder and forestomach of the rat. Cancer Lett. 21: 269-275, 1984.
29. Sakata, T. Hasegawa, R. Johansson, S. L. Zenser, T. V. and Cohen, S. M. Inhibition by aspirin of N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide initiation and sodium saccharin promotion of urinary bladder carcinogenesis in male F344 rats. Cancer Res. 46: 3903-3906, 1986.
30. Cohen, S. M. Hasegawa, R. Sakata, T. and Johansson, S. L. Effect of aspirin on urinary bladder carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]for-mamide in rats. Cancer Res. 49: 372-377, 1989.
31. Carter, C. A. Milholland, R. J. Shea, W. and Ip, M. M. Effect of the prostaglandin synthetase inhibitor indomethacin on 7,12-dimethylbenz(a)anthracene-induced mammary tumorigenesis in rats fed different levels of fat. Cancer Res. 43: 3559-3562, 1983.
32. McCormick, D. L. Madigan, M. J. and Moon, R. C. Modulation of rat mammary carcinogenesis by indomethacin. Cancer Res. 45: 1803-1808, 1985.
33. McCormick, D. L. and Wilson, A. M. Combination chemoprevention of rat mammary carcinogenesis by indomethacin and butylated hydroxytoluene. Cancer Res. 46: 3907-3911, 1986.
34. Carter, C. A. Ip, M. M. and Ip, C. A. comparison of the effects of the prostaglandin synthesis inhibitors indomethacin and carprofen on 7,12 dimethylbenz(a)anthracene-induced mammary tumorigenesis in rats fed different amounts of essential fatty acid. Carcinogenesis (Lond.), 10: 1369-1374, 1989.
35. Abou-el-ela, S. H. Prasse, K. W. Farrell, R. L. Carroll, R. W. Wade, A. E. and Bunce, O. R. Effects of D,L-2-difluoromethylornithine and indomethacin on mammary tumor promotion in rats fed high n-3 and/or n-6 fat diets. Cancer Res. 49: 1434-1440, 1989.
36. Serváis, P. Taton, G. and Galand, P. Modulation by indomethacin of diethylnitro-samine-induced early changes in c-myc and c-ras expression and late incidence of preneoplastic lesions in rat liver. Carcinogenesis (Lond.), 11: 1433-1436, 1990.
37. Taton, G. Servais, P. and Galand, P. Modulation by indomethacin or prostaglandin E2 of the incidence of diethylnitrosamine-induced glutamyltranspeptidase positive foci in rat liver. Jpn. J. Cancer Res. 81: 747-753, 1990.
38. Lynch, N. R. Castes, M. Astoin, M. and Salomon, J. C. Mechanism of inhibition of tumor growth by aspirin and indomethacin. Br. J. Cancer, 38: 503-512, 1978.
39. Sandstrom, R. Gelin, J. and Lundholm, K. The effect of indomethacin on food and water intake, motor activity and survival in tumour-bearing rats. Eur. J. Cancer, 26: 811-814, 1990.
40. Wlodarski, K. H. Indomethacin influences Moloney's sarcoma and associated periosteal osteogenesis in the mouse. Acta Orthop. Scand. 61: 427-430, 1990.
41. Hial, V. Horakova, Z. Shaff, R. E. and Beaven, M. A. Alteration of tumor growth by aspirin and indomethacin: studies with two transplantable tumors in mouse. Eur. J. Pharmacol. 37: 367-376, 1976
42. Lala, P. K. Parhar, R. S. Singh, P. and Lala, P. K. Cure of murine Ehrlich ascites tumors with chronic oral indomethacin therapy combined with intraperitoneal administration of LAK cells and IL-2. Cancer Lett. 51: 27-35, 1990.
43. Farrell, C. L. Megyesi, J. and Del Maestro, R. F. Effect of ibuprofen on tumor growth in the C6 spheroid implantation glioma model. J. Neurosurg. 68: 925-930, 1988.
44. Tanaka, Y. Tanaka, T, and Ishitsuka, H. Antitumor activity of indomethacin in mice bearing advanced colon 26 carcinoma compared with those with early transplants. Cancer Res. 49: 5935-5939, 1989.
45. Tashjian, A. H. Voelkel, E. F. Goldhaber, P. and Levine, L. Successful treatment of hypercalcemia by indomethecin in mice bearing a prostaglandin-producing fibrosarcoma. Prostaglandins, 3: 515-524, 1973.
46. Tashjian, A. H. Voelkel, E. F. Goldhaber, P. and Levine, L. Prostaglandins, calcium metabolism, and cancer. Prostaglandins, 33: 81-86, 1974.
47. Plescia, O. J. Smith, A. H. and Grinwich, K. Subversion of immune system by tumor cells and role of prostaglandins. Proc. Natl. Acad. Sci. USA, 72: 1848-1851, 1975.
48. Lynch, N. R. Castes, M. Astoin, M. and Salomon, J. C. Mechanism of inhibition of tumour growth by aspirin and indomethacin. Br. J. Cancer, 38: 503-512, 1978.
49. Shenoy, M. A. and Singh, B. B. Studies on indomethacin as a potentiator for hyperthermic and radiation responses in a mouse fibrosarcoma. Cancer Lett. 45: 227-232, 1989.
50. Mamytbekova, A. Rezabek, K. Kacerovska, H. Grimova, J. and Svobodova, J. Antimetastatic effect of flurbiprofen and other platelet aggregation inhibitors. Neoplasma (Bratisl.), 33: 417-421, 1986.
51. Mamytbekova, A. Rezabek, K. Grimova, J. and Svobodova, J. Inhibitory action of flurbiprofen and mopidamole on tumor lung metastasis formation in mice. Cancer Treat. Rep. 71: 1089-1090, 1987.
52. Bennett, A. Houghton, J. Leaper, D. J. and Stamford, I. F. Cancer growth, response to treatment and survival time in mice: beneficial effect of the prostaglandin synthesis inhibitor flurbiprofen. Prostaglandins, 17: 179-191, 1979.
53. Hillyard, L. A. and Abraham, S. Effect of dietary polyunsaturated fatty acids on growth of mammary adenocarcinomas in mice and rats. Cancer Res. 39:4430-4437, 1979.
54. Kollmorgen, G. M. King, M. M. Kosanke, S. D. and Cuong, D. Influence of dietary fat and indomethacin on the growth of transplantable mammary tumors in rats. Cancer Res. 43: 4714-4719, 1983.
55. Fulton, A. M. Inhibition of experimental metastasis with indomethacin: role of macrophages and natural killer cells. Prostaglandins, 35: 413-425, 1988.
56. Hubbard, N. E. Chapkin, R. S. and Erickson, K. L. Inhibition of growth and 1inoleate-enhanced metastasis of a transplantable mouse mammary tumor by indomethacin. Cancer Lett. 43: 111-120, 1988.
57. Bennett, A. Gaffen, J. D. Melhuish, P. B. and Stamford, I. F. Indomethacin increases the cytotoxicity of methotrexate in vitro and in vivo. Adv. Prostaglandin Thromboxane Leukotriene Res. 17: 986-988, 1987.
58. Gelin, J. Andersson, C. and Lundholm, K. Effects of indomethacin, cytokines, and cyclosporin A on tumor growth and the subsequent development of cancer cachexia. Cancer Res. 51: 880-885, 1991.
59. Lynch, N. R. and Salomon, J. C. Tumor growth inhibition and potentiation of immunotherapy by indomethacin in mice. J. Natl. Cancer Inst. 62: 117-121, 1979.
60. Weisburger, J. H. Reddy, B. S. and Joftes, D. L. Colorectal cancer. UICC Technical Report 19. Geneva: Union international Contre le Cancre, 1975.
61. Northway, M. G. Scobey, M. W. Cassidy, K. T. and Geisinger, K. R. Piroxicam decreases postirradiation colonic neoplasia in the rat. Cancer (Phila.), 66: 2300-2305, 1990.
62. Franklin, C. D. and Craig, G. T. The effect of indomethacin on tumor regression in DMBA-induced epithelial neoplasia of hamster cheek pouch mucosa. Oral Surg. 63: 335-339, 1987.
63. Feldman, J. M. and Hilf, R. Failure of indomethacin to inhibit growth of the R3230AC mammary tumor in rats. J. Natl. Cancer Inst. 75: 751-756, 1985.
64. Ellis, L. M. Copeland, E. M. Bland, K. I. and Sitren, H. S. Inhibition of tumor growth and metastasis by chronic intravenous infusion of prostaglandin E. Ann Surg. 212: 45-50, 1990.
65. Lehnen, T. Deschner, E. F. Karmali, R. A. and Decosse, J. J. Effect of flurbiprofen and 16,16 dimethyl-prostaglandin E2 on gastrointestinal tumorigenesis induced by/V-Methyl-Af’-nitro-W-nitrosoguanidine in rats. I. Squamous epithelium and mesenchymal tissue. J. Natl. Cancer Inst. 78: 923-929, 1987.
66. Lehnert, T. Deschner, E. F. Karmali, R. A. and Decosse, J. J. Effect of flurbiprofen and 16,16-dimethyl prostaglandin E2 on gastrointestinal tumorigenesis induced by N-methyl-W-nitro-W-nitrosoguanidine in rats: glandular epithelium of stomach and duodenum. Cancer Res. 50: 381-384, 1990.
67. Craven, R A. Saito, R. and Derubertis, F. R. Role of local prostaglandin synthesis in the modulation of proliferative activity of rat colonic epithelium. J. Clin. Invest. 72: 1365-1375, 1983.
68. Craven, R A. Thornburg, K. and Derubertis, F. R. Sustained increase in the proliferation of rat colonic mucosa during chronic treatment with aspirin. Gastroenterology, 94: 567-575, 1988.
69. Eastwood, G. L. and Quimby, G. F. Effects of chronic aspirin ingestion on epithelial proliferation in rat fundus, antrum, and duodenum. Gastroenterology, 82: 852-856, 1982.
70. Kuwayama, H. and Eastwood, G. L. Effects of water immersion restraint stress and chronic indomethacin ingestion on gastric antral and fundic epithelial proliferation. Gastroenterology, 88: 362-365, 1985.
71. Kune, G. Kune, S. and Watson, L. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbome Colorectal Cancer Study. Cancer Res. 48: 4399-4404, 1988.
72. Paganini-Hill, A. Chao, A. Ross, R. K. and Henderson, B. E. Aspirin use and chronic diseases: a cohort study of the elderly. Br. Med. J. 229: 1247-1250, 1989.
73. Rosenberg, L. Palmer, J. R. Zauber, A. G. Warshauer, M. E. Stolley, P. D. and Shapiro, S. A. hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J. Natl. Cancer Inst. 83: 355-358, 1991.
74. Paganini-Hill, A. Hsu, G. Ross, R. K. and Henderson, B. E. Aspirin use and incidence of large-bowel cancer in a California retirement community. J. Natl. Cancer Inst. Si: 1182-1183, 1991.
75. Rosenberg, L. Palmer, J. R. and Shapiro, S. Response. J. Natl. Cancer Inst. 83: 1183, 1991.
76. Thun, M. Namboodiri, M. and Heath, C. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med. 325: 1593-1596, 1991.
77. Labayle, D. Fischer, D. Vielh, P. et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology, 101: 635-639, 1991.
78. Lipton, A. Scialla, S. Harvey, H. et al. Adjuvant antiplatelet therapy with aspirin in colo-rectal cancer. J. Med. 23: 419-429, 1982.
79. Waddell, W. R. and Loughry, R. W. Sulindac for polyposis of the colon. J. Surg. Oncol. 24: 83-87, 1983.
80. Rigau, J. Pigué, J. M. Rubio, E. Planas, R. Tarreen, J. M. and Bordas, J. M. Effects of long-term sulindac therapy on colonic polyposis. Ann. Intern. Med. 115: 952-954, 1991.
81. Stellman, S. D. and Garfínkel, L. Smoking habits and tar levels in a new American Cancer Society prospective study of 1.2 million men and women. J. Natl. Cancer Inst. 76: 1057-1063, 1986.
82. World Health Organization. International Classification of Diseases. Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death, Vol. 1, 9th Revision. Geneva: World Health Organization, 1977.
83. Rothman, K. J. Modern Epidemiology, pp. 230-232. Boston: Little, Brown, 1986.
84. Flanders, W. D. Approximate variance formulas for standardized rate ratios. J. Chronic Dis. 37: 449-453, 1984.
85. Cox, D. R. Regression models and life tables. J. R. Stat. Soc. Ser. B., 34: 187-220, 1972.
86. Thun, M. J. Calle, E. E. Namboodiri, M. M. et al. Risk factors for fatal colon cancer in a large prospective study. J. Natl. Cancer Inst. 84: 1491-1500, 1992.
87. Isomaki, H. A. Hakulinen, T. and Joutsenlahti, U. Excess risk of lymphomas, leukemia, and myeloma in patients with rheumatoid arthritis. J. Chronic Dis. 31: 691-696, 1978.
88. Gridley, G. McLaughlin, J. K. Ekbom, A. et al. Incidence of cancer among patients with rheumatoid arthritis. J. Natl. Cancer Inst. 85: 307-311, 1993.
89. Hial, V. Demello, M. C. Horakova, Z. and Beaven, M. Antiproliferative activity of anti-inflammatory drugs in two mammalian cell culture lines. J. Pharmacol. Exp. Then, 202: 446-454, 1977.
90. Bayer, B. M. Kruth, H. S. Vaughn, M. and Beaven, M. A. Arrest of cultured cells in the G| phase of the cell cycle by indomethacin. J. Pharmacol. Exp. Ther. 210: 106-111, 1979.
91. Honn, K. VM Bookman, R. S. and Mamett, L. J. Prostaglandins and cancer: a review of tumor initiation through tumor metastasis. Prostaglandins, 21: 833-851, 1981.
92. Manning, L. S. Bowman, R. V. Davis, M. R. Musk, A. W. and Robinson, B. W. Indomethacin augments lymphokine-activated killer cell generation by patients with malignant mesothelioma. Clin. Immunol. Immunopathol. 53: 68-77, 1989.
93. Chao, T. Y. and Chu, T. M. Effect of indomethacin on tumor-infiltrating lymphocytes of a spontaneously developed murine mammary adenocarcinoma. Cancer Immunol. Immunother. 30: 158-164, 1989.
94. Honn, K. V. Busse, W D. and Sloane, B. F. Prostacyclin and thromboxanes, implications for their role in tumor cell metastasis. Biochem. Pharmacol. 3: 1-11, 1983.
95. Boring, C. C. Squires, T. S. and Tong, T. Cancer statistics, 1992. CA Cancer J. Clin. 42: 19-38, 1992.